Physician profile
Calvin David
NPI 1578719217
$12,623.79
in general payments reported to CMS, 2019-2025
26 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $508 · 2021: $3,042 · 2022: $1,484 · 2023: $3,710 · 2024: $1,481 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,032 · Travel and Lodging: $1,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,032.43 |
| Travel and Lodging | $1,831.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,744.42 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants |
| Medtronic, INC. | $1,982.68 | 2021-2025 | Signia, Ligasure, Progrip |
| Ethicon US, LLC | $1,770.71 | 2019-2025 | Stratafix, Echelon Flex, Harmonic |
| Intuitive Surgical, INC. | $1,449.13 | 2021-2023 | Da Vinci Surgical System |
| Allergan, INC. | $1,183.74 | 2019-2022 | |
| Davol INC. | $1,164.88 | 2021-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $1,062.55 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Innovation Technologies INC | $255.78 | 2021 | |
| Teleflex LLC | $245.27 | 2021-2023 | Titan Sgs Standard Gastric Stapler |
| Boston Scientific Corporation | $140.74 | 2025 | Overstitch Endoscopic Suturing System |
| Novo Nordisk INC | $119.73 | 2021-2025 | Wegovy |
| Smith+Nephew, INC. | $108.08 | 2019-2024 | Pico 7 |
| Lilly USA, LLC | $64.59 | 2024-2025 | Zepbound |
| Integra Lifesciences Corporation | $63.14 | 2019-2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $38.88 | 2019-2024 | Bridion |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $35.93 | 2020 | |
| Tei Biosciences INC | $30.39 | 2019 | |
| Hologic Sales and Service, LLC | $22.81 | 2023 | Coolseal Generator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.36 | 2025 | Xifaxan |
| Ambu INC. | $21.78 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.69 | 2019 | |
| Shire North American Group INC | $18.43 | 2019 | |
| Abbott Laboratories | $16.32 | 2019 | |
| Braintree Laboratories, INC. | $15.27 | 2020 | |
| Endo Pharmaceuticals INC. | $13.76 | 2020 | |
| Endogastric Solutions, INC | $12.73 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.